Merck said to agree to $100M NuvaRing settlement

|About: Merck & Co Inc. (MRK)|By:, SA News Editor

Merck (MRK +0.8%) reportedly agrees to pay $100M to settle more than 1,700 lawsuits alleging its NuvaRing contraceptive device causes potentially fatal blood clots.

The settlement, which resolves cases in federal and state courts in Missouri and New Jersey, would provide an average payout of more than $58K a case.

The settlement allows MRK to pay less than other competing contraceptive makers did to resolve lawsuits over their products; Bayer said last year it paid more than $1.6B to settle claims over its Yasmin and Yaz lines of birth control pills which allegedly caused blood clots that led to strokes and heart attacks.